Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinoma, Small Cell × Penfluridol × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Recurrence 1 Carcinoma, Small Cell 1

Interventions

Cisplatin 4 Etoposide 2 veliparib 1 sagopilone 1 sacituzumab govitecan 1 pomalidomide 1 pembrolizumab 1 etoposide phosphate 1 Rhenium 1 Radiation 1 Podophyllotoxin 1 Platinum 1 Penfluridol 1 Pemetrexed 1 PT-100 dipeptide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07206563 2025-10-03

Penfluridol for Relapsed/Refractory Small Cell Cancers

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 1/2 Not yet recruiting

Recurrence, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡